ALEXA KULICK: Open Payments
NPI 1518625987 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 20 payments from 8 companies in 2025. Trend: 2023 $1,126 · 2024 $1,051 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $147 |
| Novo Nordisk Inc | 5 | $111 |
| PFIZER INC. | 3 | $64 |
| Exact Sciences Corporation | 2 | $48 |
| Lilly USA, LLC | 2 | $38 |
| Astellas Pharma US Inc | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Bausch Health US, LLC | 1 | $20 |
Products named: UBRELVY, Wegovy, QULIPTA, The Cologuard Plus Collection Kit, NURTEC ODT, MOUNJARO, Veozah, LEQVIO.
Industry payments across VA — which companies pay providers there.
